SavedAdd your journal

Journals / Tüberküloz ve Toraks / 2018 / Cilt: 66 - Sayı: 2

MASK (Mobile Airways Sentinel networK) in Turkey-the ARIA integrated mobile solution for allergic rhinitis and asthma multimorbidity

Türkiye’de mask (Mobile Airways Sentinel networK) allerji günlüğü uygulaması: allerjik rinit ve astımda arıa ile bütünleşmiş mobil teknoloji kullanımı

Ayşe Arzu YORGANCIOĞLU
Cemal CİNGİ
Bilun GEMİCİOĞLU
Ruth MURRAY
Gabriel ONORATO
Slyvia ARNAVIELHE
Ömer KALAYCI
Jean BOUSQUET
Anna BEDBROOK
Ali Fuat KALYONCU
Pages
176–181
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Turkish Validation has been available and currently in use.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes.
📊
Key Findings & Data:Allergic Rhinitis and its impact on asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity MASK-rhinitis (Mobile Airways Sentinel networK), the Phase 3 ARIA initiative, is based on the freely available app.
💡
Conclusion & Impact:Turkish Validation has been available and currently in use.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. Allergic Rhinitis and its impact on asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity MASK-rhinitis (Mobile Airways Sentinel networK), the Phase 3 ARIA initiative, is based on the freely available app. The Allergy Diary is used by people who were informed by physicians, searched the internet, Apple App Store, Google Play. Turkish Validation has been available and currently in use.

Özet

Akıllı cihazlarda kullanılan aplikasyonlar gibi mobil sağlık (mHealth) uygulamaları, sağlık hizmetlerinde giderek daha yaygınlaşmakta ve daha etkin olmaktadır. Allerjik rinit ve allerjik rinitin astım üzerinde etkisi (ARIA) rehberi kanıta dayalı bulfulara dayanarak hasta yaklaşımları sunan bir rehberden allerjik rinit (AR) ve astımmorbiditesi olan olgularda gerçek yaşamda mobil teknoloji kullanan bir rehber olmaya doğru evrilmiştir. ARIA girişimi olan MASK(Mobile Airways Sentinel networK) allerji günlüğü, hekimler tarafından bu konuda bilgilendirilen kişiler tarafından, ücretsiz olarakinternetten Allergy Diary by MACVIA-ARIA olarak aratılıp, Apple’da App Store, Google’da Play Store’dan indirilebilir. Türkiye’de buaplikasyonun Türkçe validasyonu yapılmış ve kullanılmaya başlanmıştır.

🔖

Cite This Article

YORGANCIOĞLU, A. A., CİNGİ, C., GEMİCİOĞLU, B., MURRAY, R., ONORATO, G., ARNAVIELHE, S., KALAYCI, Ö., BOUSQUET, J., BEDBROOK, A., KALYONCU, A. F. (2022). MASK (Mobile Airways Sentinel networK) in Turkey-the ARIA integrated mobile solution for allergic rhinitis and asthma multimorbidity. Tüberküloz ve Toraks, Cilt: 66 - Sayı: 2, 176–181. https://ajindex.com/articles/618460

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Bousquet J, Chavannes NH, Guldemond N, Haahtela T, Hellings PW, Sheikh A. Realising the potential of mHealth to improve asthma and allergy care: how to shape the future. Eur Respir J 2017;49.pii:1700447. Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy 2016;6:47. Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J 2016;47:1028-33.
  2. Hellings PW, Borrelli D, Pietikainen S, Agache I, Akdis C, Bachert C, et al. European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017). Clin Transl Allergy 2017;7:49. Cingi C, Gevaert P, Mösges R, Röndon C, Hox V, Rudenko M, et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy 2017;7:17. Bousquet J, Schunemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol 2016;138:367-74.e2. Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy 2015;70:1372-92.
  3. Bousquet J, Onorato GL, Bachert C, Barbolini M, Bedbrook A, Bjermer L, et al. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel Network) Good Practice in allergic rhinitis: a SUNFRAIL report. Clin Transl Allergy 2017;7:37. Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, et al. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy 2016;6:29. Bousquet J, Agache I, Aliberti MR, Angles R, AnnesiMaesano I, Anto JM, et al. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIAARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). Allergy 2018;73:77-92.
  4. Bourret R, Bousquet J, Mercier J, Camuzat T, Bedbrook A, Demoly P, et al. MASK rhinitis, a single tool for integrated care pathways in allergic rhinitis. World Hosp Heal